We serve Chemical Name:DL-Sulforaphane CAS:4478-93-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:DL-Sulforaphane
CAS.NO:4478-93-7
Synonyms:UNII:41684WL1GL;1-isothiocyanato-4-methylsulfinylbutane;MFCD00198068;1-Isothiocyanato-4-(methylsulfinyl)butane;SULFORAPHANE, (±)-;4-Isothiocyanatobutyl methyl sulfoxide;4-Methylsulfinylbutyl isothiocyanate;1-Isothiocyanato-4-[(R)-methylsulfinyl]butane;4-(Methylsulfinyl)butyl isothiocyanate;1-Isothiocyanato-4-(methylsulfinyl)-butane;Butane, 1-isothiocyanato-4-[(R)-(1R)-methylsulfinyl]-;Butane, 1-isothiocyanato-4-(methylsulfinyl)-;(R)-sulforaphane;DL-Sulforaphane;(R)-1-isothiocyanato-4-(methylsulfinyl)butane;Sulforaphane;(-)-Sulforaphane;L-Sulforaphane;4-isothiocyanatobutyl methyl (R)-sulfoxide;(R)-1-Isothiocyanato-4-(methylsulfinyl)butane,4-Methylsulfinylbutyl isothiocyanate;D,L-Sulforaphane;SCN4SO&1;Sulforafan
Molecular Formula:C6H11NOS2
Molecular Weight:177.288
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:368.2±25.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.567
PSA:80.73000
Exact Mass:177.028198
LogP:0.23
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like UNII:41684WL1GL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sulforafan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(Methylsulfinyl)butyl isothiocyanate Use and application,SULFORAPHANE, (±)- technical grade,usp/ep/jp grade.
Related News: However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. DL-Sulforaphane manufacturer But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. DL-Sulforaphane supplier Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. DL-Sulforaphane vendor However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. DL-Sulforaphane factory Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.
